[1] Cheng JL, Wang XL, Yang SG, et al. Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients. World J Gastroenterol, 2017, 23(15):2802-2810. [2] Wu Z, Dong X, Wan G, et al. Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal. J Vir Hepat, 2019, 26(2):287-296. [3] Nguyen LH, Chao D, Lim JK, et al. Histologic changes in liver tissue from patients with chronic hepatitis B and minimal increases in levels of alanine aminotransferase: a meta-analysis and systematic review. Clin Gastroenterol Hepatol, 2014, 12(8):1262-1266. [4] 蒋素文, 胡爱荣, 金珊珊, 等. 丙氨酸氨基转移酶正常慢性乙型肝炎病毒感染者的肝组织病理学特征. 中华肝脏病杂志, 2016,24(12):927-929. [5] Chao DT, Lim JK, Ayoub WS, et al. Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤ 40 IU/L and significant hepatic fibrosis.Aliment Pharmacol Ther, 2014, 39(4):349-358. [6] Chong CN, Wong LH, Chan WH, et al. Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: a prospective cohort study. J Gastroenterol Hepatol, 2017, 32(2):506-514. [7] Levesque E, Martin E, Dudau D, et al. Current use and perspective of indocyanine green clearance in liver diseases. Anaesth Crit Care Pain Med, 2016, 35(1):49-57. [8] 张明明. ICG清除试验与HBeAg(+)/HBeAg(-)慢乙肝患者肝组织METAVIR评分的相关性分析.兰州:兰州大学, 2019:1-56. [9] 中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年版). 实用肝脏病杂志, 2016, 19(3):389-400. [10] 陆伟, 张占卿, 沈芳, 等. 血清 HBsAg 和 HBV DNA 定量水平预测慢性乙型肝炎患者肝组织炎症活动度和纤维化程度的评价. 实用肝脏病杂志, 2016, 19(1):20-25. [11] Liao R, Fu YP, Wang T,et al. Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma:a retrospective cohort study at two centers in China. Oncotarget, 2017, 8(1):1774-1781. [12] 王贵强, 段钟平, 王福生, 等. 慢性乙型肝炎防治指南(2019年版). 实用肝脏病杂志, 2020, 23(1):9-32. [13] Salavraakos M, Piessevaaux H, Komuta M, et al. Fibroscan reliably rules out advanced liver fibrosis and significant portal hypertension in alcoholic patients. J Clinl Gastroenterol, 2019, 53(10):772-778. [14] Chong CN, Wong LH, Chan WH, et al. Liver stiffness measurement predicts high-grade post-hepatectomy liver failure:a prospective cohort study. J Gastroenterol Hepatol, 2016, 32(2):506-514. [15] 叶细容, 吕志红, 江峰, 等. 两种超声弹性成像技术诊断慢性乙型肝炎患者肝纤维化价值比较. 实用肝脏病杂志, 2020, 23(1):18-21. [16] Cescon M, Colecchiao A, Cucchetti A, et al. Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma. Ann Surg, 2012, 256(5):706-713. [17] Qiu T, Wang H, Song J, et al. Could ultrasound elastography reflect liver function?Ultrasound Med Biol, 2018, 44(4):779-785. [18] Mobley CM, Zarrinpar A. Portable device for the analysis of liver function:a boon to liver surgery and critical care. Expert Rev Med Devices, 2016, 13(1):1-4. [19] Peyrat P, Blance E, Guillemet S, et al. Hepatofluo: a prospective monocentric study assessing the benefits of indocyanine green(ICG) fluorescence for hepatic surgery. J Surg Oncol, 2018, 117(5):922-927. [20] Yunhua T, Weiqiang J, Maogen C, et al. The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation.J Clin Monit Comput, 2018, 32(3):471-479. [21] Suresh K, Owen D, Bazzi L, et al. Using indocyanine green extraction to predict liver function after stereotactic body radiation therapy for hepatocellular carcinoma.Int J Radiat Oncol Biol Phys, 2018, 100(1):131-137. retention rate.Hepatogastroenterol, 2015, 62(140):825-828. [22] Vos JJ, Wietasch JKG, Absalom AR, et al. Green light for liver function monitoring using indocyanine green? An overview of current clinical applications. Anaesthesia, 2014, 69(12):1364-1376. |